Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549709 | PMC |
| http://dx.doi.org/10.1038/srep13045 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Real-word utility of procalcitonin in patients hospitalized with community-acquired pneumonia: A matched cohort study - CORRIGENDUM.
Infect Control Hosp Epidemiol
September 2025
Corrigendum to: real-time and noninvasive tracking of injectable hydrogel degradation using functionalized AIE nanoparticles.
Nanophotonics
August 2025
Department of Sports Medicine and Rehabilitation, Peking University Shenzhen Hospital, Shenzhen 518036, China.
[This corrects the article DOI: 10.1515/nanoph-2020-0087.].
View Article and Find Full Text PDFCorrigendum to "Real-world evidence from Türkiye on cancer risk and treatment exposure in multiple sclerosis: A histopathology-verified, registry-based study" [MSARD, Vol.100, 2025,106547].
Mult Scler Relat Disord
August 2025
Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
Corrigendum to "New severity criteria for tricuspid regurgitation in a broad population of "real life" patients: prevalence and prognostic impact" [Current Problems in Cardiology 49(2024) 102211].
Curr Probl Cardiol
October 2025
Cardiology Department, University Hospital Reina Sofía, University of Córdoba, Córdoba, Spain; Maimonides Institute for Biomedical Research of Córdoba, IMIBIC, Córdoba, Spain.
Corrigendum to "Clinical profile and cardiovascular events in patients with atrial fibrillation and hematologic malignancies with recent initiation of targeted therapy: real-life data from CANAC-FA registry" [Current Problems in Cardiology 50(2025):102974].
Curr Probl Cardiol
July 2025
Cardiology Department, Reina Sofía University Hospital, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), University of Córdoba, Avenida Menéndez Pidal s/n, Córdoba 14004, Spain; Biomedical Research Center in Cardiovascular Diseases Network (CIBER-CV), Carlos III Health Institut